Skip to main content
. 2011 Jan 31;589(Pt 7):1725–1740. doi: 10.1113/jphysiol.2010.202366

Figure 3. Intramyocardial ephrinA1-Fc administration reduces tissue injury.

Figure 3

Administration of ephrinA1-Fc resulted in a 54% reduction in cTnI serum levels 4 days after MI (A), (n = 8 control, n = 13 vehicle, n = 11 ephrinA1-Fc). Cleaved PARP expression was reduced with ephrinA1-Fc administration (B). BAG-1 protein (C) increased with ephrinA1-Fc administration by 36% when normalized to GAPDH. P < 0.05: †different from control, *different from MI.